The effects of esmolol and labetalol on cerebral blood flow velocity during electroconvulsive therapy.
van der Starre
P J A
PJ
Lemmens
H J M
HJ
Chandel
A
A
Brock-Utne
J G
JG
Solvason
H B
HB
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001783:Blood Flow Velocity / Q000187:drug effects; D001794:Blood Pressure / Q000187:drug effects; D002560:Cerebrovascular Circulation / Q000187:drug effects*; D004565:Electroconvulsive Therapy; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000517:prevention & control; D007741:Labetalol / Q000494:pharmacology*; D008297:Male; D008875:Middle Aged; D020768:Middle Cerebral Artery / Q000187:drug effects; D011412:Propanolamines / Q000494:pharmacology*; D011446:Prospective Studies; D013997:Time Factors; D017585:Ultrasonography, Doppler, Transcranial / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C036604:esmolol; D007741:Labetalol